Free CME from PeerView


Oncology CME

Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum
Neal D. Shore, MD, FACS
December 01, 2023
Credits: 1.5 CME / MOC / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Roadmap to Success With Immunotherapy's Dynamic Evolution in Metastatic, Locally Advanced, and Early-Stage NSCLC: Multidisciplinary Best Practices for Exemplary Care
Matthew A. Gubens, MD, MS, FASCO
November 30, 2023
Neal D. Shore, MD, FACS
Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient Care
Neal D. Shore, MD, FACS
November 29, 2023
Credits: 0.75 CME / NCPD / CPE / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Elevating Outcomes for HER2-Expressing GI Cancers: The Evolving Role of Molecularly Targeted Agents in BTC and GEA Care
Josep Tabernero, MD, PhD / Shubham Pant, MD
November 27, 2023
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Getting to Know the New Desmoid Tumor ICD-10-CM Codes and Why They Matter: Practical Guidance for Integrating the New Codes and Navigating the Implications
Mrinal Gounder, MD
November 26, 2023
Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Revolutionizing Solid Tumor Treatment, Unleashing the Potential of Antibody–Drug Conjugates: How to Make the Most of the Latest Clinical Evidence to Enhance Patient Care
Paolo Tarantino, MD
November 13, 2023
Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Leveling Up Our RCC Care Strategy: Real-World Translation of Key Evidence Across Treatment Settings
Sumanta Kumar Pal, MD, FASCO
November 11, 2023
Credits: 0.5 CME / MOC / CPE / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Making Choices, Improving Outcomes in Pediatric ALL: The Role of Modern Asparaginase Compounds
Luke Maese, DO
November 09, 2023
Credits: 1.5 CME / NCPD / CPE / AAPA
PVI, PeerView Institute for Medical Education
Antibody–Drug Conjugates, the Ultimate Weapons Against Solid Tumors: Latest Progress, Future Possibilities, and Implications for Patient Care
Beth Sandy, MSN, CRNP, FAPO
November 09, 2023
Credits: 1.0 CME / MOC / NCPD / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Optimizing the Care of Patients With SCLC in the Community Setting: How to Make the Most of the Latest Therapeutic Advances and Team-Based Best Practices
Ticiana Leal, MD
October 30, 2023
Credits: 1.0 CME / MOC / NCPD / CPE / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Reviving the BTK Target in MCL: Recalibrating the Treatment Sequence With Non-Covalent BTK Inhibitors in R/R Disease
Nirav Shah, MD, MS / Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD
October 26, 2023
Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Choosing Wisely, Achieving Control With BTKi in CLL: Perspectives on Safety-Informed Approaches to Enhanced Therapeutic Efficacy
John C. Byrd, MD
October 07, 2023
Credits: 1.5 CME / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Tumor Treating Fields as an Innovative Modality of Cancer Therapy: From CNS to Thoracic Malignancies and Beyond
Erik P. Sulman, MD, PhD
October 01, 2023
Credits: 1.0 CME / MOC / NCPD / CPE / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Command and Control MDS: New Science in MDS Management and Implications for Veteran-Centered Care
Michael R. Savona, MD / Andrew M. Brunner, MD
September 28, 2023
Credits: 0.75 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: Leveraging Science, Enhancing Collaboration, and Improving Outcomes With Neoadjuvant and/or Adjuvant Checkpoint Inhibition
Jessica Donington, MD
September 22, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Taking Aim With the Next Wave of Antibody–Drug Conjugates in NSCLC: Rational Strategies for Addressing the Unmet Needs of Diverse Patient Populations With TROP2- and HER3-Targeting Therapies and Other ADC-Based Regimens
Melissa L. Johnson, MD
September 11, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
A Bold Frontier: Shattering the Limits of Conventional Therapies and Reshaping the Future of Lung Cancer Treatment With TROP2-Targeting ADCs and Rational Combinations
Stephen V. Liu, MD
September 08, 2023
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
The Commanding Heights of MDS Care: Team Strategies for Delivering Modern Personalized Therapy
Guillermo Garcia-Manero, MD / Amy E. DeZern, MD, MHS
September 06, 2023
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Level Up With Personalized Care for CLL/SLL: Achieving Better Total Care With Targeted Agents & Innovative Combinations
William G. Wierda, MD, PhD / Nicole Lamanna, MD
September 06, 2023
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Expanding the Circle of Personalized AML Treatment: Expert Consults on Integrating Precision Medicine With Innovative Treatment Platforms
Naval Daver, MD / Gail J. Roboz, MD
September 06, 2023
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Setting New Expectations in Multiple Myeloma: Guidance on BCMA CAR-T & Antibody Options to Enhance Patient Care
Sagar Lonial, MD, FACP / Krina Patel, MD, MSc
September 06, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Can YOU Avoid Iatrogenic Harm? Understanding and Identifying Fibrodysplasia Ossificans Progressiva
Richard Keen, PhD, FRCP / Edna E. Mancilla, MD
August 30, 2023
Credits: 1.0 CME / MOC / NCPD / AAPA
PVI, PeerView Institute for Medical Education
Selective, Potent, Different: How to Enhance Clinical Benefits With Next-Generation ROS1 and TRK Inhibition in Treatment-Naïve and Pretreated NSCLC and Other Tumors
Alexander Drilon, MD
August 08, 2023
Credits: 1.0 CME / MOC / CC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Taking Direction From Biomarkers and Prognostic Factors in CLL: Interprofessional Strategies for Addressing Challenges With Continuous BTKi Therapy
Jennifer Woyach, MD
August 01, 2023
Credits: 0.5 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors
Mark J. Levis, MD, PhD
August 01, 2023
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC: The Latest Evidence and Practical Guidance for Biomarker Testing and Individualized Treatment Selection and Sequencing
Pasi A. Jänne, MD, PhD
July 19, 2023
Credits: 1.0 CME / MOC / AAPA / IPCE
PVI, PeerView Institute for Medical Education
The Team Takes Command in MDS: Guidance on Diagnostic and Treatment Principles for Risk-Based Care and Beyond
Guillermo Garcia-Manero, MD
July 03, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Leading the Change in Hemophilia A: Guidance on Enhancing Prophylactic Care With Innovative EHL FVIII Products
Steven W. Pipe, MD / Maria Elisa Mancuso, MD, PhD
June 23, 2023
Credits: 0.75 CME
PVI, PeerView Institute for Medical Education
“Intensity” With Efficacy in Acute Myeloid Leukemia (AML): Developing Modern, Intensive Upfront Platforms for Challenging Disease Presentations
Prof. Thomas Cluzeau, MD, PhD
June 21, 2023
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
Taking the Leap in MCL: New Opportunities With BTK Inhibitors and Other Innovative Strategies
Prof. Dr. Martin Dreyling
June 18, 2023

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView